Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Financials
Pharma
With $10B deal, AbbVie doubles down on red-hot ADC field
With the $10 billion acquisition of ImmunoGen, AbbVie hopes to redeem itself after the epic Rova-T failure.
Angus Liu
Nov 30, 2023 9:16am
Novartis puts Kisqali's peak sales potential at above $7B
Nov 28, 2023 10:48am
Coherus prices China-made PD-1 at 20% discount to Keytruda
Nov 27, 2023 6:10pm
Pharma industry reaches 'landmark' drug spending deal with UK
Nov 20, 2023 11:00am
Manufacturer NTx attracts big-name investors for $47.5M round
Nov 16, 2023 10:27am
Catalent cites impairment charge for quarterly earnings delay
Nov 14, 2023 9:55am
